MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
The completed equity investment strengthens ties between MINDCURE and ATMA.
Read moreJoin our newsletter for the latest updates, insights, and exclusive offers on everything psychedelic therapy.
